Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.10
+0.53 (3.02%)
At close: Nov 4, 2024, 4:00 PM
17.26
-0.84 (-4.64%)
After-hours: Nov 4, 2024, 4:04 PM EST
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $1.41 billion as of November 4, 2024. Its market cap has increased by 167.15% in one year.
Market Cap
1.41B
Enterprise Value
1.54B
1-Year Change
167.15%
Ranking
Category
Stock Price
$18.10
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $1.41B, an increase of 3,396.79%. That is a compound annual growth rate of 35.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 1.37B | 102.98% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.46B |
| AMN Healthcare Services | 1.46B |
| STAAR Surgical Company | 1.44B |
| Avadel Pharmaceuticals | 1.43B |
| Arcus Biosciences | 1.42B |
| Ardelyx | 1.40B |
| Progyny | 1.37B |
| Kura Oncology | 1.36B |